Abstract
The Hippo tumor suppressor pathway is a developmentally conserved signal cascade that regulates tissue growth and organ size. In line with the role in suppressing growth, the pathway is being increasingly described to suppress proliferation of cancer cells. Exactly how the Hippo tumor suppressor pathway is inactivated in cancers is not fully understood, but existing evidence supports the idea that growth promoting pathways may also serve to repress pathway activity. Interestingly, Ras signaling has become an appealing candidate for Hippo inactivation as increasing reports outline how EGFR-RAS-RAF-MEK-ERK–mediated cross talk controls Hippo signaling. Here we aim to discuss the pathway cross talk in detail, outlining the existing evidence and presenting an overview of current knowledge of the interplay between RAS and Hippo pathways.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.